Michael Lichtenauer
Impact in
-
- Cardiac Valve Diseases and Treatments
- Cardiac pacing and defibrillation studies
- Cardiovascular Function and Risk Factors
- Heart Failure Treatment and Management
- Immunology top 10%
- IL-33, ST2, and ILC Pathways
Papers in
-
- Cardiac Valve Diseases and Treatments 18
- Cardiac pacing and defibrillation studies 10
- Cardiac Fibrosis and Remodeling 8
- Viral Infections and Immunology Research 8
- Cardiovascular Function and Risk Factors 7
- Surgery 24
- Hemodynamic Monitoring and Therapy 6
- Co-authors
- Christian Jung (56 shared papers)Uta C. Hoppe (70 shared papers)Bernhard Wernly (61 shared papers)Hendrik Jan Ankersmit (20 shared papers)Marcus Franz (31 shared papers)Konrad Höetzenecker (16 shared papers)P. Christian Schulze (21 shared papers)Alexander Lauten (21 shared papers)
In The Last Decade
Michael Lichtenauer
147 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 124
- Cardiology and Cardiovascular Medicine 765
- Immunology 334
- Nephrology 82
- Genetics 109
- Surgery 419
Countries citing papers authored by Michael Lichtenauer
This map shows the geographic impact of Michael Lichtenauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Lichtenauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Lichtenauer more than expected).
Fields of papers citing papers by Michael Lichtenauer
This network shows the impact of papers produced by Michael Lichtenauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Lichtenauer. The network helps show where Michael Lichtenauer may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Lichtenauer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 150 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 115 | |
| 2 | 2018 | 97 | |
| 3 | 2018 | 93 | |
| 4 | 2017 | 85 | |
| 5 | Elevated HSP27, HSP70 and HSP90 alpha in chronic obstructive pulmonary disease: markers for immune activation and tissue destruction. | 2009 | 83 |
| 6 | 2011 | 78 | |
| 7 | 2011 | 62 | |
| 8 | 2021 | 61 | |
| 9 | 2020 | 61 | |
| 10 | 2017 | 61 | |
| 11 | 2009 | 56 | |
| 12 | 2009 | 55 | |
| 13 | 2016 | 55 | |
| 14 | 2017 | 52 | |
| 15 | 2019 | 46 | |
| 16 | 2009 | 46 | |
| 17 | 2019 | 45 | |
| 18 | 2021 | 44 | |
| 19 | 2019 | 44 | |
| 20 | 2019 | 43 |
About Michael Lichtenauer
Michael Lichtenauer is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Molecular Biology, Immunology and Physiology, having authored 150 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cardiac Valve Diseases and Treatments (18 papers), Cardiac pacing and defibrillation studies (10 papers), IL-33, ST2, and ILC Pathways (10 papers), Cardiac Fibrosis and Remodeling (8 papers), Viral Infections and Immunology Research (8 papers), Cardiovascular Function and Risk Factors (7 papers), Hemodynamic Monitoring and Therapy (6 papers) and COVID-19 Clinical Research Studies (6 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (765 citations), Immunology (334 citations), Nephrology (82 citations), Genetics (109 citations) and Surgery (419 citations). Michael Lichtenauer has collaborated with scholars based in Austria, Germany and Sweden. Frequent co-authors include Christian Jung, Uta C. Hoppe, Bernhard Wernly, Hendrik Jan Ankersmit, Marcus Franz, Konrad Höetzenecker, P. Christian Schulze, Alexander Lauten, Vera Paar and Malte Kelm. Their work appears in journals such as European Journal of Clinical Investigation, Clinical Research in Cardiology, European Heart Journal, Journal of Clinical Medicine and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.